ArticlePloS one2025
Study protocol of a pilot randomized controlled trial of transcranial direct current stimulation paired with reappraisal training for treatment of cannabis use disorder.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06369311 ([Trial of device that is not approved or cleared by the U.S. FDA]), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
[Trial of device that is not approved or cleared by the U.S. FDA]
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionAs legalization of cannabis products continues, cannabis use becomes more prevalent, and concerns regarding cannabis use disorder (CUD) rise, improving CUD treatment has become increasingly important. Techniques used to regulate emotions, such as cognitive reappraisal, may help manage cravings for cannabis in individuals with CUD. Transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique, may improve regulation of emotions and reduce substance use. This study aims to determine whether the addition of tDCS to training in cognitive reappraisal leads to greater reductions in cravings and cannabis use than cognitive reappraisal without active stimulation. METHODS AND ANALYSIS: This longitudinal between-subjects study will recruit 60 participants who will each be randomly assigned to receive either active or sham tDCS. Participants will undergo 5 sessions, each spaced approximately one week apart. In session, they will receive 20 minutes of (active/sham) 1.5mA anodal stimulation over the right dorsolateral prefrontal cortex while receiving training in cognitive reappraisal. Primary outcomes include changes in cannabis use during the study, changes in electroencephalogram brain activity when viewing cannabis cues, and changes in cannabis craving intensity. DISCUSSION: The results of this study will inform a full-scale randomized controlled trial designed to assess the effectiveness of this intervention. More broadly, these results will add to the literature on the role of tDCS in enhancing CUD treatment.
trial registrationClinicalTrials.gov NCT06369311.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.